Evidence map›Paper›PMID 17179970›Full record

GuidelineSpinal cord2007

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design.

D Lammertse, M H Tuszynski, J D Steeves, A Curt, J W Fawcett, C Rask, J F Ditunno, M G Fehlings, J D Guest, P H Ellaway and 8 more

Registry-linked trialAbstract readGuidelineReview
In one paragraph

Guideline in Spinal cord, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02899637 (Effects of High-Frequency Transcranial Magnetic Stimulation on Functional Performance of Subjects With Incomplete Spinal Cord Injury), which is not on this map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02899637 naunknown statusnot on this mapstarted 2016, after this paper: background citation

Effects of High-Frequency Transcranial Magnetic Stimulation on Functional Performance of Subjects With Incomplete Spinal Cord Injury: Study Protocol for a Randomized Controlled Trial

TypeinterventionalSponsorUniversity of Sao PauloRan2016 to 2017Enrolled30ConditionsSpinal Cord InjuryArmsActive high-frequency Transcranial Magnetic Stimulation, Sham high-frequency Transcranial Magnetic Stimulation
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2015
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Bridging the gap: a translational perspective in spinal cord injury.Experimental biology and medicine (Maywood, N.J.) · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

D LammertseCraig Hospital, Englewood, CO 80113, USA.
M H Tuszynski
J D Steeves
A Curt
J W Fawcett
C Rask
J F Ditunno
M G Fehlings
J D Guest
P H Ellaway
N Kleitman
A R Blight
B H Dobkin
R Grossman
H Katoh
A Privat
M Kalichman
International Campaign for Cures of Spinal Cord Injury Paralysis

Funding

LOCOMOTOR THERAPY TRIAL FOR SPINAL CORD INJURYU01HD037439 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOBKIN, BRUCE HARVEY · 1999 to 2003
$3.3M
NICHD NIH HHS U01 HD037439
6 · The paper itself

Abstract

The International Campaign for Cures of Spinal Cord Injury Paralysis established a panel tasked with reviewing the methodology for clinical trials for spinal cord injury (SCI), and making recommendations on the conduct of future trials. This is the fourth of four papers. Here, we examine the phases of a clinical trial program, the elements, types, and protocols for valid clinical trial design. The most rigorous and valid SCI clinical trial would be a prospective double-blind randomized control trial utilizing appropriate placebo control subjects. However, in specific situations, it is recognized that other trial procedures may have to be considered. We review the strengths and limitations of the various types of clinical trials with specific reference to SCI. It is imperative that the design and conduct of SCI clinical trials should meet appropriate standards of scientific inquiry to insure that meaningful conclusions about efficacy and safety can be achieved and that the interests of trial subjects are protected. We propose these clinical trials guidelines for use by the SCI clinical research community.

Indexed as

Clinical Trials as TopicHumansOutcome Assessment, Health CareResearch DesignSpinal Cord Injuries

Identifiers

PMID17179970
PMCPMC4106695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.